Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2909-2918

  Chen, Peter ^a   Aguilar, Oscar A ^a   Rahim, Mir Munir A ^b   Allan, David S J ^a   Fine, Jason H ^a   Kirkham, Christina L ^a   Ma, Jaehun ^a   Tanaka, Miho ^a   Tu, Megan M ^b   Wight, Andrew ^b   Kartsogiannis, Vicky ^c   Gillespie, Matthew T ^c,d   Makrigiannis, Andrew P ^b   Carlyle, James R ^a  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; H2D ANTIGEN; KLRB1B PROTEIN, MOUSE; LECTIN; MEMBRANE PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B; OCIL PROTEIN, MOUSE;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ALLOTRANSPLANTATION; ANIMAL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; DEFICIENCY; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; GRAFT REJECTION; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGEN H-2D; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84924567629     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401523     Document Type: Article

References (56)

1. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Leiter. 1992. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89: 3290-3294.
2. Goldman, J. M., R. P. Gale, M. M. Horowitz, J. C. Biggs, R. E. Champlin, E. Gluckman, R. G. Hoffmann, S. J. Jacobsen, A. M. Marmont, P. B. McGlave, et al. 1988. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann. Intern. Med. 108: 806-814.
3. Asai, O., D. L. Longo, Z. G. Tian, R. L. Hornung, D. D. Taub, F. W. Ruscetti, and W. J. Murphy. 1998. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J. Clin. Invest. 101: 1835-1842.
4. Ferrara, J. L. M., H. J ., and Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324:667-674.
5. Cudkowicz, G., and J. H. Stimpfling. 1964. Induction of immunity and of unresponsiveness to parental marrow grafts in adult F-1 hybrid mice. Nature 204: 450-453.
6. Cudkowicz, G., and J. H. Stimpfling. 1964. Hybrid resistance to parental marrow grafts: association with the K region of H-2. Science 144: 1339-1340.
7. Cudkowicz, G., and J. H. Stimpfling. 1964. Deficient growth of C57bl marrow cells transplanted in F1 hybrid mice: association with the histocompatibility-2 locus. Immunology 7: 291-306.
8. Kumar, V., T. George, Y. Y. A. Yu, J. Liu, and M. Bennett. 1997. Role of murine NK cells and their receptors in hybrid resistance. Curr. Opin. Immunol. 9: 52-56.
9. Raulet, D. H., W. Held, I. Correa, J. R. Dorfman, M. F. Wu, and L. Corral. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155: 41-52.
10. Raulet, D. H., and R. E. Vance. 2006. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6: 520-531.
11. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
12. Bennett, M. 1987. Biology and genetics of hybrid resistance. Adv. Immunol. 41: 333-445.
13. Waterfall, M., L. S. Rayfield, and L. Brent. 1984. Abrogation of resistance to bone marrow transplantation by induction of specific tolerance in natural killer cells? Nature 311: 663-665.
14. Murphy, W. J., V. Kumar, and M. Bennett. 1987. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J. Exp. Med. 165: 1212-1217.
15. Murphy, W. J., V. Kumar, and M. Bennett. 1987. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J. Exp. Med. 166: 1499-1509.
16. Tiberghien, P., D. L. Longo, J. W. Wine, W. G. Alvord, and C. W. Reynolds. 1990. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 76: 1419-1430.
17. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530.
18. Fulop, G. M., and R. A. Phillips. 1990. The scid mutation in mice causes a general defect in DNA repair. Nature 347: 479-482.
19. Dorshkind, K., S. B. Pollack, M. J. Bosma, and R. A. Phillips. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J. Immunol. 134: 3798-3801.
20. Ettinger, J., H. Geyer, A. Nitsche, A. Zimmermann, W. Brune, G. R. Sandford, G. S. Hayward, and S. Voigt. 2012. Complete genome sequence of the English isolate of rat cytomegalovirus (Murid herpesvirus 8). J. Virol. 86: 13838.
21. Voigt, S., A. Mesci, J. Ettinger, J. H. Fine, P. Chen, W. Chou, and J. R. Carlyle. 2007. Cytomegalovirus evasion of innate immunity by subversion of the NKRP1B: Clr-b missing-self axis. Immunity 26: 617-627.
22. Carlyle, J. R., A. M. Jamieson, S. Gasser, C. S. Clingan, H. Arase, and D. H. Raulet. 2004. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 101: 3527-3532.
23. Fine, J. H., P. Chen, A. Mesci, D. S. Allan, S. Gasser, D. H. Raulet, and J. R. Carlyle. 2010. Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. Cancer Res. 70: 7102-7113.
24. Chen, P., A. Mesci, and J. R. Carlyle. 2011. CELLISA: reporter cell-based immunization and screening of hybridomas specific for cell surface antigens. Methods Mol. Biol. 748: 209-225.
25. Pérarnau, B., M. F. Saron, B. Reina San Martin, N. Bervas, H. Ong, M. J. Soloski, A. G. Smith, J. M. Ure, J. E. Gairin, and F. A. Lemonnier. 1999. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29: 1243-1252.
26. Kartsogiannis, V., N. A. Sims, J. M. Quinn, C. Ly, M. Cipetic, I. J. Poulton, E. C. Walker, H. Saleh, N. E. McGregor, M. E. Wallace, et al. 2008. Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivo. J. Biol. Chem. 283: 30850-30860.
27. Rahim, M. M. A., P. Chen, A. N. Mottashed, A. B. Mahmoud, M. J. Thomas, Q. Zhu, C. G. Brooks, V. Kartsogiannis, M. T. Gillespie, J. R. Carlyle, et al. The NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses. Blood. In press.
28. Iizuka, K., O. V. Naidenko, B. F. Plougastel, D. H. Fremont, and W. M. Yokoyama. 2003. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4: 801-807.
29. Chen, P., S. Bélanger, O. A. Aguilar, Q. Zhang, A. St-Laurent, M. M. A. Rahim, A. P. Makrigiannis, and J. R. Carlyle. 2011. Analysis of the mouse 129-strain Nkrp1-Clr gene cluster reveals conservation of genomic organization and functional receptor-ligand interactions despite significant allelic polymorphism. Immunogenetics 63: 627-640.
30. Koller, B. H., P. Marrack, J. W. Kappler, and O. Smithies. 1990. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 248: 1227-1230.
31. Zijlstra, M., M. Bix, N. E. Simister, J. M. Loring, D. H. Raulet, and R. Jaenisch. 1990. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344: 742-746.
32. Bix, M., N. S. Liao, M. Zijlstra, J. Loring, R. Jaenisch, and D. Raulet. 1991. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHCmatched mice. Nature 349: 329-331.
33. Sun, K., M. Alvarez, E. Ames, I. Barao, M. Chen, D. L. Longo, D. Redelman, and W. J. Murphy. 2012. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Blood 119: 1590-1598.
34. Wu, M. F., and D. H. Raulet. 1997. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J. Immunol. 158: 1628-1633.
35. Roth, C., J. R. Carlyle, H. Takizawa, and D. H. Raulet. 2000. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 13: 143-153.
36. Patel, R., S. Bélanger, L. H. Tai, A. D. Troke, and A. P. Makrigiannis. 2010. Effect of Ly49 haplotype variance on NK cell function and education. J. Immunol. 185: 4783-4792.
37. Carlyle, J. R., A. Mesci, B. Ljutic, S. Belanger, L. H. Tai, E. Rousselle, A. D. Troke, M. F. Proteau, and A. P. Makrigiannis. 2006. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J. Immunol. 176: 7511-7524.
38. Carlyle, J. R., A. Martin, A. Mehra, L. Attisano, F. W. Tsui, and J. C. Zúñiga-Pflücker. 1999. Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J. Immunol. 162: 5917-5923.
39. Kung, S. K. P., R. C. Su, J. Shannon, and R. G. Miller. 1999. The NKR-P1B gene product is an inhibitory receptor on SJL/J NK cells. J. Immunol. 162: 5876-5887.
40. Plougastel, B., C. Dubbelde, and W. M. Yokoyama. 2001. Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics 53: 209-214.
41. Zhou, H., V. Kartsogiannis, J. M. Quinn, C. Ly, C. Gange, J. Elliott, K. W. Ng, and M. T. Gillespie. 2002. Osteoclast inhibitory lectin, a family of new osteoclast inhibitors. J. Biol. Chem. 277: 48808-48815.
42. Tian, W., R. Nunez, S. Cheng, Y. Ding, J. Tumang, C. Lyddane, C. Roman, and H. C. Liou. 2005. C-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell proliferation and IL-2 production. Cell. Immunol. 234: 39-53.
43. Tian, W., B. Feng, and H. C. Liou. 2005. Silencing OCILRP2 leads to intrinsic defects in T cells in response to antigenic stimulation. Cell. Immunol. 235: 72-84.
44. Carlyle, J. R., A. Mesci, J. H. Fine, P. Chen, S. Bélanger, L. H. Tai, and A. P. Makrigiannis. 2008. Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol. 20: 321-330.
45. Higuchi, D. A., P. Cahan, J. Gao, S. T. Ferris, J. Poursine-Laurent, T. A. Graubert, and W. M. Yokoyama. 2010. Structural variation of the mouse natural killer gene complex. Genes Immun. 11: 637-648.
46. Zhou, H., V. Kartsogiannis, Y. S. Hu, J. Elliott, J. M. Quinn, W. J. McKinstry, M. T. Gillespie, and K. W. Ng. 2001. A novel osteoblast-derived C-type lectin that inhibits osteoclast formation. J. Biol. Chem. 276: 14916-14923.
47. Ciechanover, A., A. L. Schwartz, and H. F. Lodish. 1983. Sorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptors. J. Cell. Biochem. 23: 107-130.
48. Aust, J. G., F. Gays, K. M. Mickiewicz, E. Buchanan, and C. G. Brooks. 2009. The expression and function of the NKRP1 receptor family in C57BL/6 mice. J. Immunol. 183: 106-116.
49. Gur, C., A. Porgador, M. Elboim, R. Gazit, S. Mizrahi, N. Stern-Ginossar, H. Achdout, H. Ghadially, Y. Dor, T. Nir, et al. 2010. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 11: 121-128.
50. Bilsland, C. A., and C. Milstein. 1991. The identification of the beta 2-microglobulin binding antigen encoded by the human CD1D gene. Eur. J. Immunol. 21: 71-78.
51. Vance, R. E., J. R. Kraft, J. D. Altman, P. E. Jensen, and D. H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841-1848.
52. Orr, M. T., and L. L. Lanier. 2011. Inhibitory Ly49 receptors on mouse natural killer cells. Curr. Top. Microbiol. Immunol. 350: 67-87.
53. Ito, D., Y. M. Iizuka, M. P. Katepalli, and K. Iizuka. 2009. Essential role of the Ly49A stalk region for immunological synapse formation and signaling. Proc. Natl. Acad. Sci. USA 106: 11264-11269.
54. Doucey, M. A., L. Scarpellino, J. Zimmer, P. Guillaume, I. F. Luescher, C. Bron, and W. Held. 2004. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5: 328-336.
55. Held, W., and R. A. Mariuzza. 2008. Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat. Rev. Immunol. 8: 269-278.
56. Back, J., E. L. Malchiodi, S. Cho, L. Scarpellino, P. Schneider, M. C. Kerzic, R. A. Mariuzza, and W. Held. 2009. Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity 31: 598-608.